help button home button Am J Pathol R & D Systems
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Material
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ferrari, C. C.
Right arrow Articles by Pitossi, F. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ferrari, C. C.
Right arrow Articles by Pitossi, F. J.
(American Journal of Pathology. 2004;165:1827-1837.)
© 2004 American Society for Investigative Pathology

Reversible Demyelination, Blood-Brain Barrier Breakdown, and Pronounced Neutrophil Recruitment Induced by Chronic IL-1 Expression in the Brain

Carina C. Ferrari*, Amaicha M. Depino*, Federico Prada*, Nara Muraro*, Sandra Campbell{dagger}, Osvaldo Podhajcer*, V. Hugh Perry{ddagger}, Daniel C. Anthony{dagger} and Fernando J. Pitossi*

From the Leloir Institute,* University of Buenos Aires, Consejo Nacional de Investigaciones Científicas y Técnicas, Buenos Aires, Argentina; the Molecular Neuropathology Laboratory,{dagger} School of Biological Sciences, University of Southampton, Southampton, and the CNS Inflammation Group,{ddagger} School of Biological Sciences, University of Southampton, Southampton, United Kingdom

Interleukin-1ß (IL-1) expression is associated with a spectrum of neuroinflammatory processes related to chronic neurodegenerative diseases. The single-bolus microinjection of IL-1 into the central nervous system (CNS) parenchyma gives rise to delayed and localized neutrophil recruitment, transient blood-brain barrier (BBB) breakdown, but no overt damage to CNS integrity. However, acute microinjections of IL-1 do not mimic the chronic IL-1 expression, which is a feature of many CNS diseases. To investigate the response of the CNS to chronic IL-1 expression, we injected a recombinant adenovirus expressing IL-1 into the striatum. At the peak of IL-1 expression (days 8 and 14 post-injection), there was a marked recruitment of neutrophils, vasodilatation, and breakdown of the BBB. Microglia and astrocyte activation was evident during the first 14 days post-injection. At days 8 and 14, extensive demyelination was observed but the number of neurons was not affected by any treatment. Finally, at 30 days, signs of inflammation were no longer present, there was evidence of tissue reorganization, the BBB was intact, and the process of remyelination was noticeable. In summary, our data show that chronic expression of IL-1, in contrast to its acute delivery, can reversibly damage CNS integrity and implicates this cytokine or downstream components as major mediators of demyelination in chronic inflammatory and demyelinating diseases.




This article has been cited by other articles:


Home page
 BrainHome page
M. C. P. Godoy, R. Tarelli, C. C. Ferrari, M. I. Sarchi, and F. J. Pitossi
Central and systemic IL-1 exacerbates neurodegeneration and motor symptoms in a model of Parkinson's disease
Brain, July 1, 2008; 131(7): 1880 - 1894.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
T. A. Brooks, N. Nametz, R. Charles, and T. P. Davis
Diclofenac Attenuates the Regional Effect of {lambda}-Carrageenan on Blood-Brain Barrier Function and Cytoarchitecture
J. Pharmacol. Exp. Ther., May 1, 2008; 325(2): 665 - 673.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
S. S. Shaftel, T. J. Carlson, J. A. Olschowka, S. Kyrkanides, S. B. Matousek, and M. K. O'Banion
Chronic Interleukin-1{beta} Expression in Mouse Brain Leads to Leukocyte Infiltration and Neutrophil-Independent Blood Brain Barrier Permeability without Overt Neurodegeneration
J. Neurosci., August 29, 2007; 27(35): 9301 - 9309.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
M. Deckert, S. Virna, M. Sakowicz-Burkiewicz, S. Lutjen, S. Soltek, H. Bluethmann, and D. Schluter
Interleukin-1 Receptor Type 1 Is Essential for Control of Cerebral but Not Systemic Listeriosis
Am. J. Pathol., March 1, 2007; 170(3): 990 - 1002.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
P. Banerjee, R. Rochford, J. Antel, G. Canute, S. Wrzesinski, M. Sieburg, and G. Feuer
Proinflammatory Cytokine Gene Induction by Human T-Cell Leukemia Virus Type 1 (HTLV-1) and HTLV-2 Tax in Primary Human Glial Cells
J. Virol., February 15, 2007; 81(4): 1690 - 1700.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. T. Argaw, Y. Zhang, B. J. Snyder, M.-L. Zhao, N. Kopp, S. C. Lee, C. S. Raine, C. F. Brosnan, and G. R. John
IL-1beta Regulates Blood-Brain Barrier Permeability via Reactivation of the Hypoxia-Angiogenesis Program
J. Immunol., October 15, 2006; 177(8): 5574 - 5584.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. S. Paintlia, M. K. Paintlia, I. Singh, and A. K. Singh
IL-4-Induced Peroxisome Proliferator-Activated Receptor {gamma} Activation Inhibits NF-{kappa}B Trans Activation in Central Nervous System (CNS) Glial Cells and Protects Oligodendrocyte Progenitors under Neuroinflammatory Disease Conditions: Implication for CNS-Demyelinating Diseases
J. Immunol., April 1, 2006; 176(7): 4385 - 4398.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
S. D. Bilbo, J. C. Biedenkapp, A. Der-Avakian, L. R. Watkins, J. W. Rudy, and S. F. Maier
Neonatal Infection-Induced Memory Impairment after Lipopolysaccharide in Adulthood Is Prevented via Caspase-1 Inhibition
J. Neurosci., August 31, 2005; 25(35): 8000 - 8009.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American Society for Investigative Pathology.